The accuracy of a several popular consumer smart devices for detecting atrial fibrillation (AF) did not improve over a ...

Two studies presented at AHA show the capacity of AI to improve sonographer accuracy, consistency, and workflow.

Though the results aren’t definitive, it’s not premature to suggest high-risk individuals take shelter on very hot days.

In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer ...

A nasal spray would be a workaround for drug resistance seen with oral diuretics, with the potential to reduce hospital ...

The mixed, counterintuitive results hinder trial interpretation, but along with ARREST-AF, experts still see actionable ...

The two strategies, used to reduce renal, brain, and heart injury after surgery, were ineffective, but the story isn’t done.

Part 2 of this 7,000-patient trial suffered from discontinuations and low event rates: still, early MRAs did not impact CV ...

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...

Amidst discrepant SPRINT and ACCORD data, this study confirms the benefits seen in nondiabetics, Shawna Nesbitt says.

The prevalence of obesity and overweight is extraordinarily high. Unsurprisingly, deaths related to obesity are on the rise, ...

Low event rates and short TTRs with warfarin were notable, and questions persist as to which patients truly need OAC.